Shire plc : Rule 2.9 Announcement
June 11, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
June 08, 2018 02:00 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
June 07, 2018 02:00 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 announcement
June 06, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Director/PDMR Shareholding
June 04, 2018 10:01 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding June 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the...
Shire plc : Rule 2.9 Announcement
June 04, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : New Data on the Cardiovascular Safety of Prucalopride Presented at 2018 Digestive Disease Week Annual Meeting
June 03, 2018 14:45 ET
|
Shire Pharmaceuticals Group
New Data on the Cardiovascular Safety of Prucalopride Presented at 2018 Digestive Disease Week Annual Meeting New data from this observational, pharmacoepidemiology safety study included...
Shire plc : Total voting rights
June 01, 2018 07:01 ET
|
Shire Pharmaceuticals Group
Total Voting Rights June 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and...
Shire plc : Rule 2.9 Announcement
June 01, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
May 31, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....